BEAM - Beam Therapeutics Inc.
IEX Last Trade
26.77
0.050 0.187%
Share volume: 17,763
Last Updated: Fri 27 Dec 2024 08:30:24 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$26.72
0.05
0.19%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-07 | 2023-02-28 | 2023-05-10 | 2023-08-08 | 2023-11-08 | 2024-02-27 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 1.418 B | 1.350 B | 1.342 B | 1.332 B | 1.354 B | 1.291 B | 1.460 B | 1.360 B | |
| Current Assets | 1.180 B | 1.109 B | 1.093 B | 1.083 B | 1.095 B | 1.040 B | 1.211 B | 1.122 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 13.775 M | 14.358 M | 14.762 M | 23.560 M | 21.789 M | 24.084 M | 21.167 M | 27.156 M | |
| Short Term Investments | 13.775 M | 14.358 M | 14.762 M | 23.560 M | 21.789 M | 24.084 M | 21.167 M | 27.156 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.166 B | 1.095 B | 1.078 B | 1.059 B | 1.073 B | 1.015 B | 1.190 B | 1.095 B | |
| Total Non-current Assets | 238.485 M | 241.338 M | 248.818 M | 249.321 M | 259.082 M | 250.993 M | 248.671 M | 238.086 M | |
| Property Plant Equipment | 106.090 M | 111.180 M | 115.620 M | 121.822 M | 128.203 M | 127.521 M | 124.960 M | 120.922 M | |
| Other Assets | 2.223 M | 1.874 M | 1.931 M | 1.538 M | 1.382 M | 2.652 M | 2.146 M | 1.689 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.418 B | 1.350 B | 1.342 B | 1.332 B | 1.354 B | 1.291 B | 1.460 B | 1.360 B | |
| Total liabilities | 618.214 M | 635.773 M | 608.240 M | 570.846 M | 542.244 M | 511.593 M | 478.385 M | 446.306 M | |
| Total current liabilities | 212.278 M | 238.859 M | 223.595 M | 219.925 M | 209.536 M | 220.365 M | 205.565 M | 187.219 M | |
| Accounts Payable | 7.095 M | 7.024 M | 9.029 M | 14.063 M | 6.886 M | 3.177 M | 1.617 M | 2.790 M | |
| Other liabilities | 240.164 M | 230.451 M | 214.866 M | 184.640 M | 167.982 M | 130.287 M | 112.909 M | 103.148 M | |
| Current long term debt | 2.389 M | 2.210 M | 1.853 M | 1.421 M | 912.000 K | 1.084 M | 0.000 | 0.000 | |
| Long term debt | 1.787 M | 1.388 M | 1.154 M | 983.000 K | 875.000 K | 304.000 K | 0.000 | 0.000 | |
| Other liabilities | 240.164 M | 230.451 M | 214.866 M | 184.640 M | 167.982 M | 130.287 M | 112.909 M | 103.148 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 800.161 M | 714.477 M | 733.474 M | 761.506 M | 811.643 M | 778.941 M | 981.329 M | 913.490 M | |
| Common stock | 70.210 M | 70.343 M | 70.804 M | 72.274 M | 76.335 M | 79.025 M | 80.973 M | 81.699 M | |
| Retained earnings | -909.438 M | -1.019 B | -1.057 B | -1.154 B | -1.237 B | -1.333 B | -1.190 B | -1.289 B |